FibroGen
FGEN
#9414
Rank
โ‚น3.31 B
Marketcap
โ‚น32.89
Share price
0.62%
Change (1 day)
-19.47%
Change (1 year)

Revenue for FibroGen (FGEN)

Revenue in 2024 (TTM): โ‚น14.48 Billion

According to FibroGen's latest financial reports the company's current revenue (TTM ) is โ‚น14.67 Billion. In 2023 the company made a revenue of โ‚น12.30 Billion an increase over the revenue in the year 2022 that were of โ‚น11.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for FibroGen from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น14.48 B17.73%
2023 โ‚น12.30 B5.62%
2022 โ‚น11.64 B-33.51%
2021 โ‚น17.51 B35.82%
2020 โ‚น12.89 B-29.52%
2019 โ‚น18.29 B22.87%
2018 โ‚น14.89 B63.35%
2017 โ‚น9.11 B-25.3%
2016 โ‚น12.20 B1.55%
2015 โ‚น12.01 B37.79%
2014 โ‚น8.72 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น373.87 B 2,448.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.51 B-35.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.03 B-92.96%๐Ÿ‡บ๐Ÿ‡ธ USA